Trials / Completed
CompletedNCT07206680
Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 55 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the therapeutic effect of shockwave therapy on reducing pruritus in neurodermatitis patients.
Detailed description
Based on the occurrence of side effects caused by conventional medication for prolonged employment, dermatologists and patients show solicitude for multifaceted effective methods to control the chronic and relapsing nature of neurodermatitis. Although new modalities are continuously coming up for pruritus, there remains a great gap for providing symptom relief. Furthermore, there is a lack in the quantitative knowledge and information in the published studies about benefits of shockwave therapy on the treatment of pruritus in neurodermatitis patients. So, this study is designed to outline the therapeutic efficacy of shockwave therapy on the treatment of pruritus in neurodermatitis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Shockwave therapy | The procedures for Extracorporeal Shockwave Therapy (ESWT) involve several steps. First, the patient is positioned comfortably, and the physiotherapist explains the treatment procedure. Before the session begins, the device cables are checked for proper functioning. The shockwave type used is Non-Focused/Radial, with a treatment duration not exceeding 10 minutes. The frequency is set at 4 Hz, and the intensity ranges from 0.05 to 0.20 mJ/mm². Each session involves a total of 1000 to 2000 shocks. The treatment consists of four sessions, each held once a week. |
| DRUG | Emollients & corticosteroids | Patients in both groups will receive emollients \& corticosteroids for one month. |
Timeline
- Start date
- 2024-12-15
- Primary completion
- 2025-09-15
- Completion
- 2025-10-25
- First posted
- 2025-10-03
- Last updated
- 2026-03-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07206680. Inclusion in this directory is not an endorsement.